Healthcare Professional Survey to Assess the Effectiveness of Risk Evaluation and Mitigation Strategy for Dulaglutide (H9X-MC-B002)

16/08/2016
18/08/2017
EU PAS number:
EUPAS14792
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

H9X-MC-B002_Registered

English (241.41 KB - PDF) View document
Study results
Study report
Other information